Abveris on-demand webinar 03/10/2022

Anti-Idiotypic mAb Discovery Part II: Anti-Ids against engineered biologics and CAR-Ts


Ryan Kelly, Director of Business Development 

Anti-Idiotypic antibodies (anti-Id) are critical assay reagents used in PK/ADA assays for therapeutic biologics entering clinical trials. Ensuring the timely readiness of high-quality, assay-ready anti-Id is a top-priority task for all bioanalytical groups. In this webinar, the Abveris team will discuss how to de-risk anti-Id discovery in terms of screening platform and strategy selection. In the second of this two-part webinar series, the following topics will be discussed:

1. Challenges for anti-Id discovery for cell-based biologics

2. Case study of an anti-Id discovery campaign for a CAR-T product

Talk to a Scientist



More free webinars!

Here are more on-demand webinars that our team has put together for you


Have any questions?

Click the link below to schedule a meeting with one of our scientists!

Talk to a Scientist